PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
NCT: NCT03983512 · ACTIVE_NOT_RECRUITING
NCT IDNCT03983512
StatusACTIVE_NOT_RECRUITING
Start Date2019-10-07
Completion2026-12
Brief Summary
The purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of congenital or acquired pulmonary valve stenosis and/or regurgitation who require pulmonary valve replacement.
Frequently Asked Questions
What is PULSTA Transcatheter Pulmonary Valve Pre-Approval Study?
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study is a clinical trial registered under NCT03983512. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT03983512?
The current status of NCT03983512 (PULSTA Transcatheter Pulmonary Valve Pre-Approval Study) is: ACTIVE_NOT_RECRUITING.
When did PULSTA Transcatheter Pulmonary Valve Pre-Approval Study start?
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study started on 2019-10-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.